Cannabinoids as Treatment for Hemophilic Arthropathy: Hypothesized Molecular Pathways
Authors
Abstract
Hemophilia is a recessive X linked hereditary disease which causes coagulation problems. In severe cases, one of the most common issues is hemophilic arthropathy (HA) leading to a range of problems such as joint pain, swelling, crippling and decreased range of motion. Regarding pathogenesis of this phenomenon, the main consequence is emerged as repeated episodes of bleeding leading to inflammation, angiogenesis and synovium hypertrophy. These pathways are triggered and directed by some cytokines and growth factors such as IL-1, IL-6, TNF-α, HIF-α, VEGF and MMP-9. Cannabinoids (CBNs) are active compounds of Cannabis Sativa known for their highly potent anti-angiogenic and anti-inflammatory activity. In molecular aspects, they are able to suppress all mentioned cytokines, growth factors and even more angiogenic regulators such as Ang-1 and Ang2. Here we suggested that CBNs could be valid candidates for targeting HA due to their anti-inflammatory and anti-angiogenic activity.
Highlights
Copyright
© 2016, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Coagulation and Angiogenesis in Cancer-Review Article
Mansouri K, Oubari F, Shamllo S, Ahmadi P, Kashani M. Coagulation and Angiogenesis in Cancer-Review Article. J Clin Res Paramed Sci. 2016;5(2):e81465. doi:
Survey of the relationship between of thrombophilic factors and the rate and severity of bleeding in patients with severe hemophilia A
Faranosh M, Danayie N, Ghorbani R, Rahamani M, Jazebi M, et al. Survey of the relationship between of thrombophilic factors and the rate and severity of bleeding in patients with severe hemophilia A. koomesh. 2024;9(4):e152211. doi:
Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders
Bamedi T, Dadashizadeh G, Sarabandi A, Tabibian S, Shams M, et al. Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders. J Cell Mol Anesth. 2017;2(1):e149529. doi: https://doi.org/10.22037/jcma.v2i1.14481
Acne Treatment Based on Cannabinoids: Efficacy and Legislation Perspectives
Pocay Araujo H, Giovanetti Esteves Santos T, Sobreira Mendonca Goncalves F, Alves Balista P, Vieira Gonzaga R, et al. Acne Treatment Based on Cannabinoids: Efficacy and Legislation Perspectives. J Skin Stem Cell. 2025;12(1):e157752. doi: https://doi.org/10.5812/jssc-157752
Perioperative Management of Acquired Hemophilia A: A Case Report and Review of Literature
Ilkhchoui Y, Koshkin E, Windsor JJ, Petersen TR, Charles M, et al. Perioperative Management of Acquired Hemophilia A: A Case Report and Review of Literature. Anesth Pain Med. 2014;4(1):e11906. doi: https://doi.org/10.5812/aapm.11906
More by these authors
- Scopus by DOI: 0
Last Update: 4 days ago
- Scopus by Title: 5
Last Update: 4 days ago
- Scopus by Title (Ref): 5
Last Update: 4 days ago
- CrossRef: 0
Last Update: 8 hours ago
- OpenAlex: 0
Last Update: 11 hours ago
- OpenCitations: 0
Last Update: 5 days ago